EUVIMEDEUVIMED entdecken
Crossref

Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma

Sijin Li, Zhen Chen, Mengchu Liu, Liang Li, Wensong Cai, Zhe-Xiong Lian, Haixia Guan, Bo Xu iD

Endocrine-Related Cancer · 2024

DOI: 10.1530/erc-23-0240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Sijin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Goiter. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of Treg cell subsets is critical for the prognosis of tumor patients; however, their heterogeneity and disease association in papillary thyroid carcinoma (PTC) need further investigation. We performed high-dimensional flow cytometry for immunophenotyping on thyroid tissues and matched peripheral blood samples from patients with multinodular goiters or PTC. We analyzed CD4 + T cell and Treg cell phenotypes and compared the recurrence-free survival of PTC patients with different Treg cell subset characteristics using TCGA. Furthermore, PTC recurrent and non-recurrent group were compared by multiplex immunohistochemistry. High-dimensional flow cytometry and bioinformatics analysis revealed an enrichment of Tregs in tumors compared with multinodular goiters and peripheral blood specimens. Moreover, effector Tregs (e-Tregs) as well as FOXP3 + non-Tregs were enriched in tumor samples, and the expression of CD39, PD-1, and CD103 increased on tumor Tregs. TCGA data analysis showed that individuals with CD39 hi PD-1 lo CD103 lo e-Treg hi and CD39 lo PD-1 lo CD103 hi e-Treg hi expression patterns had a high recurrence rate. According to the multiplex immunohistochemistry and analysis, compared with non-recurrent group, the proportion of high recurrence rate effector Treg clusters (CD39 + PD-1 − CD103 − plus CD39 − PD-1 − CD103 + ) was increased in recurrent patients. Overall, our results highlight the potential of e-Treg subsets as future immunotherapy targets for PTC recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsGoiterHumansT-Lymphocytes, RegulatoryThyroid Cancer, PapillaryImmunophenotypingFlow CytometryProgrammed Cell Death 1 Receptor

Stichwörter der Autor:innen

Tregflow cytometrypapillary thyroid carcinomarecurrence

Substanzen

Programmed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Thyroid Surgery, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Department of Thyroid Surgery, Guangzhou First People's Hospital, Guangzhou, China.
  • School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, China.
  • Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

ORCID-Profile: Bo Xu

Zitieren

APA

Li, S., Chen, Z., Liu, M., Li, L., Cai, W., Lian, Z. X., Guan, H., & Xu, B. (2024). Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0240

Vancouver

Li S, Chen Z, Liu M, Li L, Cai W, Lian ZX, et al. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma. Endocrine-Related Cancer. 2024. doi:10.1530/erc-23-0240

BibTeX
@article{Li2024,
  author = {Li, Sijin and Chen, Zhen and Liu, Mengchu and Li, Liang and Cai, Wensong and Lian, Zhe-Xiong and Guan, Haixia and Xu, Bo},
  title = {Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2024},
  doi = {10.1530/erc-23-0240}
}
Kostenlos starten →